Your browser version may not work well with NCBI's Web applications. More information here...
1: J Am Acad Dermatol. 2008 Aug;59(2):295-315. Epub 2008 Apr 14.Click here to read Links
Comment in:
J Am Acad Dermatol. 2009 Apr;60(4):705.

Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases.

Lam J, Polifka JE, Dohil MA.

Department of Pediatrics, Division of Dermatology, Rady Children's Hospital, University of California, San Diego, California, USA.

In patients with psoriasis, there is an increased availability of drugs for treatment. However, there are important questions about drug safety for mothers with psoriasis and their fetuses. Currently, there are limited safety data for many of the medications used. In this article, we review current pregnancy risk information for medications commonly used in the treatment of psoriasis. In addition, a list of teratology information resources is included to help practicing clinicians find up-to-date information regarding the safety of the medications they prescribe.

PMID: 18410980 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Acitretin (Soriatane® )

    Acitretin is used to treat severe psoriasis (abnormal growth of skin cells that causes red, thickened, or scaly skin). Acitretin is in a class of medications called retinoids. The way acitretin works is not known.

  • Source: AHFS Consumer Medication Information